Myers Robert P, Shaheen Abdel Aziz M, Li Bing, Dean Stafford, Quan Hude
Liver Unit, Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Clin Gastroenterol Hepatol. 2008 Aug;6(8):918-25; quiz 837. doi: 10.1016/j.cgh.2008.02.053. Epub 2008 May 16.
BACKGROUND & AIMS: Acetaminophen overdose is the most common cause of acute liver failure in the U.S. and other Western countries. Unintentional overdoses, alcohol abuse, and underlying liver disease might increase the risk of hepatotoxicity. In this population-based study, we examined outcomes of acetaminophen overdose, with particular attention to these risk factors.
Patients hospitalized for acetaminophen overdose between 1995 and 2004 were identified retrospectively by using administrative data. Comorbid conditions, suicidal intent, and hepatotoxicity were identified by using International Classification of Diseases-Ninth Revision-Clinical Modification and International Statistical Classification of Diseases and Health-Related Problems, 10th revision diagnostic codes.
During the 10-year interval, 1543 patients were hospitalized for acetaminophen overdose; 34% were alcohol abusers, 3% had liver disease, and 13% overdosed unintentionally. Seventy patients (4.5%) developed hepatotoxicity. Unintentional overdoses (odds ratio [OR], 5.18; 95% confidence interval [CI], 3.00-8.95), alcohol abuse (OR, 2.21; 95% CI, 1.30-3.76), underlying liver disease (OR, 3.50; 95% CI, 1.57-7.77), and N-acetylcysteine treatment (OR, 6.75; 95% CI, 2.78-16.39) were independently associated with hepatotoxicity. Fifteen patients (1.0%) died in-hospital; risk factors included older age, unintentional overdoses, alcohol abuse, comorbidities including liver disease, and hepatotoxicity (14% vs 0.3%; P < .0005). During a median follow-up of 5.2 years (range, 1 day-11.0 years), 79 patients (5.1%) died. Approximately half of these deaths were due to preventable conditions including suicide, substance abuse, and trauma.
In this population-based study, acetaminophen overdose had a relatively benign short-term course but was associated with substantial long-term mortality caused by preventable conditions. Acetaminophen-related hepatotoxicity is more common in patients with unintentional overdoses, alcohol abuse, and underlying liver disease.
对乙酰氨基酚过量服用是美国及其他西方国家急性肝衰竭最常见的病因。意外过量服药、酗酒及潜在的肝脏疾病可能会增加肝毒性风险。在这项基于人群的研究中,我们调查了对乙酰氨基酚过量服用的后果,尤其关注这些风险因素。
通过使用管理数据回顾性地确定1995年至2004年间因对乙酰氨基酚过量服用而住院的患者。使用国际疾病分类第九版临床修订本及国际疾病与相关健康问题统计分类第十版诊断编码确定合并症、自杀意图及肝毒性。
在这10年期间,1543例患者因对乙酰氨基酚过量服用而住院;34%为酗酒者,3%患有肝脏疾病,13%为意外过量服药。70例患者(4.5%)发生了肝毒性。意外过量服药(比值比[OR],5.18;95%置信区间[CI],3.00 - 8.95)、酗酒(OR,2.21;95% CI,1.30 - 3.76)、潜在肝脏疾病(OR,3.50;95% CI,1.57 - 7.77)及N - 乙酰半胱氨酸治疗(OR,6.75;95% CI,2.78 - 16.39)与肝毒性独立相关。15例患者(1.0%)在医院死亡;风险因素包括年龄较大、意外过量服药、酗酒、包括肝脏疾病在内的合并症以及肝毒性(14%对0.3%;P < 0.0005)。在中位随访5.2年(范围,1天 - 11.0年)期间,79例患者(5.1%)死亡。这些死亡中约一半是由于可预防的情况,包括自杀、药物滥用和创伤。
在这项基于人群的研究中,对乙酰氨基酚过量服用短期病程相对良性,但与由可预防情况导致的显著长期死亡率相关。对乙酰氨基酚相关肝毒性在意外过量服药、酗酒及潜在肝脏疾病患者中更为常见。